Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study

BACKGROUND: The Republic of Congo adopted a new anti-malarial treatment policy in 2006, with artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) as the first- and second-line anti-malarial drugs, respectively. Only three clinical studies had been conducted before the policy change. A rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndounga, Mathieu, Pembe Issamou Mayengue, Casimiro, Prisca Nadine, Koukouikila-Koussounda, Félix, Bitemo, Michel, Diassivy Matondo, Brunelle, Ndounga Diakou, Lee Aymar, Basco, Leonardo K., Ntoumi, Francine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625922/
https://www.ncbi.nlm.nih.gov/pubmed/26511848
http://dx.doi.org/10.1186/s12936-015-0918-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625922/
https://www.ncbi.nlm.nih.gov/pubmed/26511848
http://dx.doi.org/10.1186/s12936-015-0918-6

Ejemplares similares